Companies: 10,795·Total market cap: $144.5T
Omada Health

Omada Health

OMDANASDAQHealthcare● Active
$17.88
$-0.05(-0.28%)
Market Cap$1.1B
P/E Ratio
52W High$26.915
52W Low$10.28
Overview

Omada Health (OMDA) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

omda · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Omada Health (OMDA) measures how much investors pay for each dollar of the company's trailing earnings. OMDA's current PE ratio of N/A is calculated by dividing its stock price of $17.88 by its TTM earnings per share of -$0.11.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
86.80x
FY2027 est. EPS $0.21
Based on 4 analysts
EPS (TTM)
-$0.11
TTM · diluted EPS
PEG Ratio
-0.78
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Omada Health SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2022 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Healthcare Information Services · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Omada Health
Omada HealthYou
OMDA
$1.1BN/A-$0.11
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.
BCRX
$1.8B6.20x-98.2%$1.26
Maze Therapeutics, Inc.
Maze Therapeutics, Inc.
MAZE
$1.3BN/A-$3.05
Omnicell, Inc.
Omnicell, Inc.
OMCL
$1.9B1014.72x+188.6%$0.04
Progyny, Inc.
Progyny, Inc.
PGNY
$2.0B37.40x-89.4%$0.69
Phreesia, Inc.
Phreesia, Inc.
PHR
$577M347.91x-1.0%$0.04
Schrödinger, Inc.
Schrödinger, Inc.
SDGR
$1.1BN/A-$1.41
Industry Average
4 peers with valid PE
351.56xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.22
2024-12-31
FY2024
$-0.85
2023-12-31
FY2023
$-1.21
2022-12-31
FY2022
$-1.30

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Omada Health (OMDA) measures how much investors pay for each dollar of the company's trailing earnings. OMDA's current PE ratio of N/A is calculated by dividing its stock price of $17.88 by its TTM earnings per share of -$0.11.

PE Ratio = Stock Price ÷ EPS (TTM)
= $17.88 ÷ -$0.11 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

OMDA pe ratio · 6 questions

OMDA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $17.88 and TTM EPS of -$0.11. Data sourced from Financial Modeling Prep via OMDA's SEC 10-K and 10-Q filings.

OMDA PE ratioWhat is OMDA PE ratioCurrent PE ratio of OMDAOMDA PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Omada Health SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09